학술논문
Molecular imaging and fluid biomarkers of Alzheimer's disease neuropathology: an opportunity for integrated diagnostics.
Document Type
Editorial
Source
Subject
*ALZHEIMER'S disease
*NEUROLOGICAL disorders
*
Language
ISSN
1619-7070
Abstract
Finally, experts in integrated diagnostics in AD would be the ideal partner for clinicians to appropriately build diagnostic algorithms and accelerate an evidence-based larger scale adoption of AD biomarkers. 12 Ramusino MC, Garibotto V, Bacchin R, Altomare D, Dodich A, Assal F. Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease. This article is part of the Topical Collection on Neurology - Dementia Alzheimer's disease (AD) gold standard diagnosis is the detection of amyloid plaques and neurofibrillary aggregates of hyperphosphorylated tau at autopsy. There are only a few diagnostic studies measuring this parameter [[10]-[12]], one in this issue comparing the incremental diagnostic value of amyloid PET and tau PET [[13]]. [Extracted from the article]